The immunomodulatory effects of macrolides—a systematic review of the underlying mechanisms

P Zimmermann, VC Ziesenitz, N Curtis… - Frontiers in …, 2018 - frontiersin.org
Background The mechanisms underlying the non-antimicrobial immunomodulatory
properties of macrolides are not well understood. Objectives To systematically review the …

Inflammation in cystic fibrosis: An update

EA Roesch, DP Nichols, JF Chmiel - Pediatric pulmonology, 2018 - Wiley Online Library
Inflammation plays a critical role in cystic fibrosis (CF) lung pathology and disease
progression making it an active area of research and important therapeutic target. In this …

Azithromycin: mechanisms of action and their relevance for clinical applications

MJ Parnham, VE Haber… - Pharmacology & …, 2014 - Elsevier
Azithromycin is a macrolide antibiotic which inhibits bacterial protein synthesis, quorum-
sensing and reduces the formation of biofilm. Accumulating effectively in cells, particularly …

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health

PJ Mogayzel Jr, ET Naureckas… - American journal of …, 2013 - atsjournals.org
Rationale: Cystic fibrosis (CF) is an autosomal recessive disease characterized by abnormal
airways secretions, chronic endobronchial infection, and progressive airway obstruction …

Nonantimicrobial actions of macrolides: overview and perspectives for future development

JA Kricker, CP Page, FR Gardarsson… - Pharmacological …, 2021 - ASPET
Macrolides are among the most widely prescribed broad spectrum antibacterials, particularly
for respiratory infections. It is now recognized that these drugs, in particular azithromycin …

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non–cystic fibrosis bronchiectasis: the BAT randomized controlled trial

J Altenburg, CS de Graaff, Y Stienstra, JH Sloos… - Jama, 2013 - jamanetwork.com
Importance Macrolide antibiotics have been shown beneficial in cystic fibrosis (CF) and
diffuse panbronchiolitis, and earlier findings also suggest a benefit in non-CF …

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial

C Wong, L Jayaram, N Karalus, T Eaton, C Tong… - The Lancet, 2012 - thelancet.com
Background Azithromycin is a macrolide antibiotic with anti-inflammatory and
immunomodulatory properties. We tested the hypothesis that azithromycin would decrease …

Mechanisms of action and clinical application of macrolides as immunomodulatory medications

S Kanoh, BK Rubin - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Macrolides have diverse biological activities and an ability to modulate inflammation and
immunity in eukaryotes without affecting homeostatic immunity. These properties have led to …

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind …

S Uzun, RS Djamin, JAJW Kluytmans… - The Lancet …, 2014 - thelancet.com
Background Macrolide resistance is an increasing problem; there is therefore debate about
when to implement maintenance treatment with macrolides in patients with chronic …

Antibiotic-induced biofilm formation

JB Kaplan - The International journal of artificial organs, 2011 - journals.sagepub.com
Surface-attached colonies of bacteria known as biofilms play a major role in the
pathogenesis of device-related infections. Biofilm colonies are notorious for their resistance …